| Literature DB >> 29072698 |
Xuefeng Wei1, Hui Li1, Jiameng Yang1, Dan Hao1, Dong Dong1, Yongzhen Huang1, Xianyong Lan1, Martin Plath1, Chuzhao Lei1, Fengpeng Lin2, Yueyu Bai3, Hong Chen1.
Abstract
Circular RNAs (circRNAs) have been identified from various tissues and species, but their regulatory functions during developmental processes are not well understood. We examined circRNA expression profiles of two developmental stages of bovine skeletal muscle (embryonic and adult musculus longissimus) to provide first insights into their potential involvement in bovine myogenesis. We identified 12 981 circRNAs and annotated them to the Bos taurus reference genome, including 530 circular intronic RNAs (ciRNAs). One parental gene could generate multiple circRNA isoforms, with only one or two isoforms being expressed at higher expression levels. Also, several host genes produced different isoforms when comparing development stages. Most circRNA candidates contained two to seven exons, and genomic distances to back-splicing sites were usually less than 50 kb. The length of upstream or downstream flanking introns was usually less than 105 nt (mean≈11 000 nt). Several circRNAs differed in abundance between developmental stages, and real-time quantitative PCR (qPCR) analysis largely confirmed differential expression of the 17 circRNAs included in this analysis. The second part of our study characterized the role of circLMO7-one of the most down-regulated circRNAs when comparing adult to embryonic muscle tissue-in bovine muscle development. Overexpression of circLMO7 inhibited the differentiation of primary bovine myoblasts, and it appears to function as a competing endogenous RNA for miR-378a-3p, whose involvement in bovine muscle development has been characterized beforehand. Congruent with our interpretation, circLMO7 increased the number of myoblasts in the S-phase of the cell cycle and decreased the proportion of cells in the G0/G1 phase. Moreover, it promoted the proliferation of myoblasts and protected them from apoptosis. Our study provides novel insights into the regulatory mechanisms underlying skeletal muscle development and identifies a number of circRNAs whose regulatory potential will need to be explored in the future.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29072698 PMCID: PMC5680912 DOI: 10.1038/cddis.2017.541
Source DB: PubMed Journal: Cell Death Dis Impact factor: 8.469
Summary of reads mapping to the Bos taurus reference genome
| Raw reads | 111,340,382 | 106,866,166 | 134,501,982 | 139,160,360 | 101,780,186 | 101,084,070 |
| Clean reads | 88,317,616 | 80,238,976 | 104,670,312 | 108,467,672 | 85,317,802 | 84,111,208 |
| Mapped reads | 54,979,060 | 49,922,182 | 62,333,225 | 88,546,667 | 53,810,383 | 58,188,271 |
| Mapping ratio | 68.31% | 68.17% | 70.01% | 84.18% | 83.67% | 84.47% |
| Uniquely mapped reads | 50,334,911 | 45,233,401 | 57,170,376 | 86,082,724 | 52,330,653 | 56,687,937 |
| Unique mapping ratio | 62.54% | 61.77% | 64.21% | 81.84% | 81.37% | 82.29% |
Figure 1Identification of circular RNAs in bovine skeletal muscle tissue. (a) Workflow for the preparation and analysis of circRNA libraries, (b) Venn diagram depicting different circRNAs uncovered at two developmental stages (embryonic and adult tissues), and (c) origin of circRNAs described in this study in the bovine genome
Results from the assembly of circRNAs
| Number | 12,981 | 63 | 822 | 279 | 1,054 | 55,635 | 10,675,372 |
Figure 2Profiling of circular RNAs in bovine skeletal muscle. (a) Size distribution of circRNAs and (b) of the respective host genes, (c) Circos plot showing the distribution of circRNAs in different chromosomes, (d) numbers of back-spliced reads in circRNAs, (e–g) lengths of flanking introns, and (h) circRNAs that contained varying numbers of exons. (i) Genomic distances of back-splicing sites of most circRNAs ranged within 50 kb, with only few circRNAs spanning 100–300 kb
The top 10 most up-regulated circRNAs at the adult stage compared to the embryonic stage
| circRNA2388 | 1869.81 | 179.54 | 3.38 | 1.18E−06 | |
| circRNA4692 | 63.83 | 1.21 | 5.72 | 7.67E−06 | |
| circRNA1039 | 59.08 | 7.68 | 2.94 | 7.74E−06 | |
| circRNA1170 | 47.37 | 10.52 | 2.17 | 2.36E−05 | |
| circRNA1169 | 45.70 | 11.63 | 1.97 | 4.28E−05 | |
| circRNA4486 | 60.63 | 2.43 | 4.64 | 7.12E−05 | |
| circRNA6958 | 2.80 | 0.00 | ‘Infinite’ | 8.05E−05 | |
| circRNA7890 | 191.18 | 0.00 | ‘Infinite’ | 1.24E−04 | |
| circRNA8739 | 0.88 | 0.00 | ‘Infinite’ | 1.33E−04 | |
| circRNA8876 | 21.67 | 0.00 | ‘Infinite’ | 1.71E−04 |
The top 10 most down-regulated circRNAs at the adult stage compared to the embryonic stage
| circRNA1012 | 1.66 | 6.09 | −1.88 | 1.93E−05 | |
| circRNA736 | 3.09 | 13.50 | −2.13 | 3.94E−05 | |
| circRNA421 | 1.40 | 3.22 | −1.20 | 6.11E−05 | |
| circRNA1557 | 0.23 | 5.96 | −4.71 | 9.28E−05 | |
| circRNA1710 | 1.54 | 5.16 | −1.74 | 1.51E−04 | |
| circRNA2033 | 1.63 | 9.31 | −2.51 | 2.01E−04 | |
| circRNA2414 | 0.90 | 3.12 | −1.80 | 2.24E−04 | |
| circRNA684 | 1.74 | 28.12 | −4.02 | 3.71E−04 | |
| circRNA1493 | 0.00 | 4.06 | ‘-Infinite’ | 3.78E−04 | |
| circRNA603 | 0.00 | 1.23 | ‘-Infinite’ | 5.02E−04 |
Differentially expressed circRNAs with high overall expression levels in embryonic or adult muscle tissue
| circRNA941 | 0.00 | 704.61 | ‘-Infinite’ | 5.59E−03 | |
| circRNA942 | 0.00 | 585.48 | ‘-Infinite’ | 3.39E−03 | |
| circRNA939 | 0.00 | 405.17 | ‘-Infinite’ | 1.84E−02 | |
| circRNA1009 | 11.63 | 83.17 | −2.84 | 3.98E−03 | |
| circRNA893 | 27.14 | 72.05 | −1.41 | 1.37E−02 | |
| circRNA2374 | 0.00 | 69.93 | ‘-Infinite’ | 2.14E−03 | |
| circRNA1783 | 0.61 | 68.94 | −6.82 | 8.17E−04 | |
| circRNA17 | 0.29 | 52.32 | −7.48 | 2.40E−02 | |
| circRNA1126 | 1.39 | 46.92 | −5.07 | 9.52E−03 | |
| circRNA2252 | 0.00 | 46.24 | ‘-Infinite’ | 1.15E−03 | |
| circRNA2388 | 1869.81 | 179.54 | 3.38 | 1.18E−06 | |
| circRNA7651 | 1062.90 | 0.00 | ‘Infinite’ | 6.30E−04 | |
| circRNA9247 | 669.34 | 0.00 | ‘Infinite’ | 3.07E−02 | |
| circRNA5844 | 632.39 | 0.00 | ‘Infinite’ | 4.22E−02 | |
| circRNA615 | 516.82 | 6.15 | 6.39 | 1.03E−02 | |
| circRNA7018 | 507.49 | 0.00 | ‘Infinite’ | 8.54E−03 | |
| circRNA8529 | 479.14 | 0.00 | ‘Infinite’ | 1.06E−02 | |
| circRNA341 | 387.54 | 37.98 | 3.35 | 2.11E−02 | |
| circRNA7112 | 365.82 | 0.00 | ‘Infinite’ | 4.00E−03 | |
| circRNA1565 | 354.61 | 45.38 | 2.97 | 1.73E−03 |
Figure 3Differentially expressed circular RNAs in bovine skeletal muscle. (a) Clustered heat map of the top 100 most differentially expressed circRNAs when comparing embryonic and adult muscle tissues, and (b) scatter plot showing the correlation between abundances of individual circRNAs at the embryonic and adult stage
Figure 4Characteristics of circular RNA in bovine skeletal muscle. (a) Clustered heat map showing abundances of the corresponding linear host transcripts of the top 100 most differentially expressed circRNAs. (b) Numbers of circRNAs produced by the same gene. (c) Exemple of circATRX, which showed six alternative circRNA isoforms. (d, e) Box plots showing abundances of differentially expressed circRNA isoforms. The first four circRNAs are presented
Differential expression patterns of circRNAs and linear mRNA from their parental host genes in two developmental stages of bovine muscle tissue
| Adult>embryonic (62) | Adult>embryonic | 32 | ||
| Adult<embryonic | 2 | |||
| Adult≈embryonic | 28 | |||
| Adult>embryonic (39) | Adult>embryonic | 11 | ||
| Adult<embryonic | 2 | |||
| Adult≈embryonic | 26 |
Figure 5Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. Shown are the top 20 GO (a) and KEGG (b) terms of host genes from which differentially expressed circRNAs were uncovered
Figure 6Validation of putative circular RNA by quantitative real-time PCR (qPCR). (a) Schematic view illustrating the design of primers for circRNAs used in qPCR. (b) 17 circRNAs that were selected as they exhibited significantly different expression patterns (assessed from our RNA-sequencing approach) when comparing two development stages. (c) Representative examples of PCR products purified and sequenced to confirm circRNA junction sequences. (d) Validation of differential expression of circRNAs using qPCR, whereby 17 circRNAs confirmed the predicted pattern, while two circRNAs Data are presented as means±S.E.M. for three individuals. *P<0.05
Figure 7Expression analysis of circLMO7 using qPCR. (a) Expression levels of circLMO7 in different tissues of embryonic cattle. (b) Visualization of the efficiency of circLMO7 overexpression vector pcDNA-circLMO7. (c) Effect of circLMO7 on the abundance of miR-378a-3p. (d) RNAhybrid predicted a miR-378a-3p binding site and provided ΔG values for its interaction with circLMO7. (e) Our miR-378a-3p overexpression vector was co-transfected with psiCHECK2-circLMO7W or psiCHECK2-circLMO7M into bovine primary myocytes. Renilla luciferase activity was normalized to Firefly luciferase activity. (f) mRNA expression of HDAC4 in primary bovine myocytes transfected with circLMO7 and/or miR-378a-3p mimic for 24 h was detected using qPCR. Data are shown as means±S.E.M. for three individuals. *P<0.05
Figure 8circLMO7 suppresses the differentiation of bovine primary myocytes. (a) Bovine primary myocytes were transfected with pcDNA-circLMO7 and/or miR-378a-3p mimic, and cell differentiation was detected by immunofluorescence. (b) mRNA of marker genes for myocyte differentiation were detected by qPCR. (c) The presence of proteins translated from marker genes of myocyte differentiation were analyzed using western blots
Figure 9circLMO7 promotes the proliferation of bovine primary myocytes. (a, b) Bovine primary myocytes were transfected with pcDNA-circLMO7 and/or miR-378a-3p mimic, and cell phases were analyzed by flow cytometry. (c) Cell proliferation was assessed using the cell counting kit-8 (CCK-8) assay. (d) mRNA of the proliferation marker CyclinD1 was quantified using qPCR. (e) Cell proliferation indices were assessed after treatment with 5-Ethynyl-2′-deoxyuridine (EdU). The scale bar represents 200 μm. Data are presented as means±S.E.M. for three individuals. *P<0.05
Figure 10circLMO7 inhibits apoptosis in bovine primary myocytes. (a, b) We transfected bovine primary myocytes with pcDNA-circLMO7 and/or miR-378a-3p mimic and determined apoptosis by Annexin V-FITC/PI binding followed by flow cytometry. (c) mRNA of apoptosis marker genes (BCL-2, BAX, caspase9) was detected using qPCR. (d) Proteins of apoptosis marker genes were detected using western blots. Data are presented as means±S.E.M. for three individuals. *P<0.05